Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
China Biopharma's $56.7B Deal Boom Signals Pillar Industry Dominance in 2026
Wednesday, April 01, 2026Chinese innovative drug outlicensing deals have surged since early totaling billion across agreements underscoring Chinas rising dominance in global biopharma
Infinimmune Enters into Collaboration with Merck to Advance Human Antibody Discovery
Wednesday, April 01, 2026Infinimmune has entered into a collaboration with Merck MSD outside the United States and Canada to discover and develop novel human antibody therapeutics across multiple undisclosed targets
Abbisko Therapeutics’ Irpagratinib Receives EMA Orphan Drug Status for Liver Cancer
Wednesday, April 01, 2026Abbisko Therapeutics has received orphan drug designation from the European Medicines Agency for its FGFR inhibitor irpagratinib aimed at treating hepatocellular carcinoma HCC
Sanofi’s Rezurock Receives Approval for Chronic Graft-versus-host Disease
Tuesday, March 31, 2026Sanofi has received conditional marketing authorisation from the European Commission for Rezurock belumosudil to treat chronic graftversushost disease GVHD
ImmuneOncia Therapeutics Enters into Collaboration with Lonza to Manufacture Danburstotug for Immuno-Oncology
Tuesday, March 31, 2026ImmuneOncia Therapeutics has entered into a manufacturing agreement with Lonza to support the latestage clinical supply of its investigational immunooncology therapy Danburstotug IMC
Biocytogen reports FDA IND clearance for NEOK Bio’s NEOK002 targeting solid tumours
Friday, March 27, 2026Biocytogen Pharmaceuticals Beijing Co Ltd has announced that its partner NEOK Bio Inc has received investigational new drug IND clearance from the US Food and Drug Administration for NEOK an antibodydrug conjugate ADC targeting EGFR and MUC for the t...
Novartis to acquire Excellergy to strengthen next-generation anti-IgE pipeline
Friday, March 27, 2026Novartis has agreed to acquire Excellergy Inc a private biotechnology company focused on developing nextgeneration antiIgE therapies for IgEdriven diseases The deal will add Exl a highaffinity halflife extended antiIgE antibody currently in Phase de...
Novo Nordisk receives US approval for once-weekly basal insulin Awiqli®
Friday, March 27, 2026Novo Nordisk AS has received approval from the US Food and Drug Administration for Awiqli insulin icodecabae unitsmL a onceweekly longacting basal insulin for adults with type diabetes The treatment is indicated as an addition to diet and exercise...
Asia Drives Pharmaceutical Growth in 2026 with China Leading Biopharma Innovation and Production Surge
Thursday, March 26, 2026Asia is spearheading global pharmaceutical expansion in propelled by Chinas dominance in biopharma innovation advanced manufacturing and strategic RD investments
Corcept Therapeutics Receives Approval for Relacorilant Combination Therapy in Platinum-Resistant Ovarian Cancer
Thursday, March 26, 2026Corcept Therapeutics has received approval from the US Food and Drug Administration for relacorilant Lifyorli in combination with nabpaclitaxel to treat adults with platinumresistant epithelial ovarian fallopian tube or primary peritoneal cancer who...
